Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich
Press Release
Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich
Kaiseraugst (Switzerland), Maastricht (Netherlands), April 8, 2025
dsm-firmenich, innovators in nutrition, health, and beauty, is pleased to announce the appointment of Laetitia Pictet as Chief Legal, Risk and Compliance Officer (CLRCO), effective May 1, 2025. She succeeds Jane Sinclair, who is retiring after a distinguished career.
Laetitia Pictet brings over 25 years of senior legal expertise across Europe, the Americas, and Asia. She currently serves as SVP Corporate Secretary and Enterprise Risk Management and has been an invaluable senior member in the company’s legal team since joining in 2015. In her new role as CLRCO, Laetitia will join the company’s Executive Committee, reporting directly to CEO Dimitri de Vreeze.
Jane Sinclair retires as dsm-firmenich’s Chief Legal, Risk, Regulatory and Compliance Officer on April 30, 2025, after nearly a decade in the role and a legal career spanning more than three decades. Her extensive experience includes senior advisory roles in corporate law, general counsel, company secretary, corporate governance, capital markets, M&A, and corporate litigation. Jane will stay on as advisor to the CEO through the end of 2026.
Dimitri de Vreeze, CEO, commented: “I am thrilled to welcome Laetitia to our Executive Committee as Chief Legal, Risk and Compliance Officer. Her exceptional skills and dedication are a tremendous asset to our company. Laetitia’s deep legal expertise and unwavering commitment to excellence are consistently driving impactful results, fostering a culture of integrity and compliance. I am also deeply grateful for Jane’s leadership and outstanding legal counsel during a period of significant transformation at dsm-firmenich. Her astute guidance and significant contributions have been invaluable in establishing dsm-firmenich. We will miss her warm personality and great spirit, and we wish her all the best in her well-deserved retirement.”
Laetitia, a Swiss national, began her legal career in the pharmaceutical industry. She joined Firmenich as VP Senior Legal Counsel in 2015 and was swiftly promoted to SVP Head of Commercial Legal in 2018. In 2021, she took on the additional role of Secretary of the Board. Following the completion of the merger in 2023, Laetitia assumed the responsibilities of Corporate Secretary for dsm-firmenich, alongside Risk Management.
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
www.dsm-firmenich.com
For more information
Media relations
Robin Roothans
tel. +41 (0)79 280 03 96
e-mail media@dsm-firmenich.com
Investor relations
Dave Huizing
tel. +31 (0)88 425 7306
e-mail investors@dsm-firmenich.com
Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance, transaction progress and positions to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of this press release prevails over other language versions.
Attachment
